A Aviles

Summary

Affiliation: National Medical Center

Publications

  1. ncbi Radiotherapy versus combined therapy in early stages with bulky disease aggressive malignant lymphoma
    Agustin Avilés
    Oncology Research Unit, Oncology Hospital, National Medical Center, IMSS, Mexico, DF, Mexico
    Hematology 8:7-10. 2003
  2. ncbi Treatment of refractory Hodgkin's disease with modified Stanford V program
    A Aviles
    Oncological Research Unit, Oncology Hospital, National Medical Center, IMSS, Mexico, DF
    Med Oncol 18:261-7. 2001
  3. ncbi Spinal cord compression as a primary manifestation of aggressive malignant lymphomas: long-term analysis of treatments with radiotherapy, chemotherapy or combined therapy
    Agustin Avilés
    Research Unit in Oncological Diseases, Oncology Hospital, National Medical Center, IMSS, Mexico, DF, Mexico
    Leuk Lymphoma 43:355-9. 2002
  4. ncbi Large bowel lymphoma: an analysis of prognostic factors and therapy in 53 patients
    Agustin Avilés
    Department of Hematology, Oncology Hospital, National Medical Center, I M S S, Mexico D F, Mexico
    J Surg Oncol 80:111-5. 2002
  5. ncbi Combined therapy in the treatment of primary mediastinal B-cell lymphoma: conventional versus escalated chemotherapy
    A Aviles
    Research Unit in Oncology Diseases, Oncology Hospital, National Medical Center, Instituto Mexicano del Seguro Social, Apartado Postal 7 1220, 06700, Mexico D F, Mexico
    Ann Hematol 81:368-73. 2002
  6. ncbi Gemcitabine and cisplatin in refractory malignant lymphoma
    Agustin Avilés
    Oncology Research Unit, Mexican Social Security Institute, Mexico City, Mexico
    Oncology 66:197-200. 2004
  7. ncbi Nasal NK/T-cell lymphoma with disseminated disease treated with aggressive combined therapy
    Agustin Avilés
    Oncological Research Unit, Oncology Hospital, National Medical Center, IMSS, Mexico
    Med Oncol 20:13-7. 2003
  8. ncbi Lack of prognostic factors in follicular lymphoma
    Agustin Avilés
    Oncology Research Unit, The Oncology Hospital, National Medical Center, IMSS, Mexico, DF, Mexico
    Leuk Lymphoma 44:143-7. 2003
  9. ncbi Treatment of advanced Hodgkin's disease: EBVD versus intensive brief chemotherapy
    Agustin Avilés
    Oncology Research Unit, Oncology Hospital, National Medical Center, IMSS, Mexico, D F, Mexico
    Leuk Lymphoma 44:1361-5. 2003
  10. ncbi Maintenance therapy with interferon-alpha 2b, cyclophosphamide, and prednisone in aggressive diffuse large cell lymphoma
    Agustin Avilés
    Oncology Research Unit, Oncology Hospital, National Medical Center, IMSS, Mexico, D F Mexico
    Stem Cells Dev 13:205-9. 2004

Detail Information

Publications32

  1. ncbi Radiotherapy versus combined therapy in early stages with bulky disease aggressive malignant lymphoma
    Agustin Avilés
    Oncology Research Unit, Oncology Hospital, National Medical Center, IMSS, Mexico, DF, Mexico
    Hematology 8:7-10. 2003
    ..We conclude that combined therapy appear to be superior in patients with early stages and bulky disease in patients with aggressive malignant lymphoma...
  2. ncbi Treatment of refractory Hodgkin's disease with modified Stanford V program
    A Aviles
    Oncological Research Unit, Oncology Hospital, National Medical Center, IMSS, Mexico, DF
    Med Oncol 18:261-7. 2001
    ..A controlled clinical trial in untreated patients comparing the Stanford program with standard chemotherapy is warranted to define the role of this therapeutic option in patients with Hodgkin's disease...
  3. ncbi Spinal cord compression as a primary manifestation of aggressive malignant lymphomas: long-term analysis of treatments with radiotherapy, chemotherapy or combined therapy
    Agustin Avilés
    Research Unit in Oncological Diseases, Oncology Hospital, National Medical Center, IMSS, Mexico, DF, Mexico
    Leuk Lymphoma 43:355-9. 2002
    ..The use of combined therapy improves the outcome in this group of patients, and so it should be considered the treatment of choice...
  4. ncbi Large bowel lymphoma: an analysis of prognostic factors and therapy in 53 patients
    Agustin Avilés
    Department of Hematology, Oncology Hospital, National Medical Center, I M S S, Mexico D F, Mexico
    J Surg Oncol 80:111-5. 2002
    ....
  5. ncbi Combined therapy in the treatment of primary mediastinal B-cell lymphoma: conventional versus escalated chemotherapy
    A Aviles
    Research Unit in Oncology Diseases, Oncology Hospital, National Medical Center, Instituto Mexicano del Seguro Social, Apartado Postal 7 1220, 06700, Mexico D F, Mexico
    Ann Hematol 81:368-73. 2002
    ..Patients with pleural or pericardial effusion are considered at high risk for failure with the actual programs of treatment and probably will be considered for experimental therapeutic approaches...
  6. ncbi Gemcitabine and cisplatin in refractory malignant lymphoma
    Agustin Avilés
    Oncology Research Unit, Mexican Social Security Institute, Mexico City, Mexico
    Oncology 66:197-200. 2004
    ..We performed a pilot study to evaluate the effect of the high-dose gemcitabine-cisplatin combination in a brief weekly regimen in the treatment of primary refractory diffuse large cell lymphoma with high or high-intermediate clinical risk...
  7. ncbi Nasal NK/T-cell lymphoma with disseminated disease treated with aggressive combined therapy
    Agustin Avilés
    Oncological Research Unit, Oncology Hospital, National Medical Center, IMSS, Mexico
    Med Oncol 20:13-7. 2003
    ..The use of intensive more specific chemotherapy and high dose of local radiotherapy, appear to be an excellent therapeutic approach with improvement in EFS and OS...
  8. ncbi Lack of prognostic factors in follicular lymphoma
    Agustin Avilés
    Oncology Research Unit, The Oncology Hospital, National Medical Center, IMSS, Mexico, DF, Mexico
    Leuk Lymphoma 44:143-7. 2003
    ....
  9. ncbi Treatment of advanced Hodgkin's disease: EBVD versus intensive brief chemotherapy
    Agustin Avilés
    Oncology Research Unit, Oncology Hospital, National Medical Center, IMSS, Mexico, D F, Mexico
    Leuk Lymphoma 44:1361-5. 2003
    ..In the present single center trial, intensive chemotherapy did not appear to have better results when compared with standard chemotherapy in patients with advanced Hodgkin's disease...
  10. ncbi Maintenance therapy with interferon-alpha 2b, cyclophosphamide, and prednisone in aggressive diffuse large cell lymphoma
    Agustin Avilés
    Oncology Research Unit, Oncology Hospital, National Medical Center, IMSS, Mexico, D F Mexico
    Stem Cells Dev 13:205-9. 2004
    ..We conclude that use of maintenance therapy combining interferon-alpha 2b, cyclophosphamide, and prednisone is not useful in patients with aggressive lymphoma if they had been treated with aggressive combined chemotherapy...
  11. ncbi Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero
    A Aviles
    Oncology Diseases Research Unit, Oncology Hospital, National Medical Center, IMSS, Mexico, D F, Mexico
    Clin Lymphoma 2:173-7. 2001
    ....
  12. ncbi Adjuvant radiotherapy in stage IV diffuse large cell lymphoma improves outcome
    Agustin Avilés
    Oncology Hospital, National Medical Center, IMSS, Mexico, DF, Mexico
    Leuk Lymphoma 45:1385-9. 2004
    ..Thus, we felt that adjuvant radiotherapy will be considered as part of the initial treatment in this setting of patients...
  13. ncbi Novel therapy in multiple myeloma
    Agustin Avilés
    Oncology Research Unit, Department of Hematology, Oncology Hospital, National Medical Center, IMSS, Mexico, D F Mexico
    Invest New Drugs 23:411-5. 2005
    ..Controlled clinical trials comparing with conventional chemotherapy will be conducted to define the role of this therapeutic approach...
  14. ncbi Late cardiac toxicity secondary to treatment in Hodgkin's disease. A study comparing doxorubicin, epirubicin and mitoxantrone in combined therapy
    Agustin Avilés
    Oncology Research Unit, Oncology Hospital, National Medical Center, IMSS, Mexico, D F Mexico
    Leuk Lymphoma 46:1023-8. 2005
    ..Thus, we would not recommend use of the drug in Hodgkin's disease. ERNA and echocardiogram are early detection tests for cardiac toxicity and can be employed in surveillance studies...
  15. ncbi Mucosa-associated lymphoid tissue (MALT) lymphoma of the stomach: results of a controlled clinical trial
    Agustin Avilés
    Oncology Research Unit, National Medical Center, IMSS, Mexico
    Med Oncol 22:57-62. 2005
    ..Thus considered, chemotherapy alone is an effective and safe therapeutic approach in this setting of patients. Surgery or radiotherapy will be reserved to patients that are not candidates for chemotherapy...
  16. ncbi Biological modifiers as cytoreductive therapy before stem cell transplant in previously untreated patients with multiple myeloma
    A Aviles
    Oncology Research Unit and Department of Hematology, Oncology Hospital National Medical Center, Mexico, D F Mexico
    Ann Oncol 16:219-21. 2005
    ..The use of biological modifiers has not been considered in this situation. We developed a new cytoreductive regimen, in an attempt to retain clinical efficacy but reduce toxicity...
  17. ncbi Interferon alpha 2b as maintenance therapy improves outcome in follicular lymphoma
    Agustin Avilés
    Oncology Research Unit, Oncology Hospital, National Medical Center, IMSS, Mexico, D F Mexico
    Leuk Lymphoma 45:2247-51. 2004
    ..The use of aggressive chemotherapy and maintenance therapy with interferon alpha 2b in follicular lymphoma improved outcome; more than 60% of patients remain alive free of disease at longer follow-up...
  18. ncbi Intensive chemotherapy in the treatment of aggressive diffuse large B-cell lymphoma: malignant lymphoma
    Agustin Avilés
    Oncology Research Unit, Oncology Hospital, National Medical Center, IMSS, Mexico, D F Mexico
    Med Oncol 21:269-72. 2004
    ..The intensive CEOP-Bleo regimen with increasing doses of cyclophosphamide and epirubicin is a useful and well-tolerated regimen in the treatment of poor prognosis diffuse large B-cell lymphoma...
  19. pmc The role of surgery in primary gastric lymphoma: results of a controlled clinical trial
    Agustin Avilés
    Oncology Research Unit, Oncology Hospital, National Medical Center, IMSS, Mexico
    Ann Surg 240:44-50. 2004
    ....
  20. ncbi Interferon alfa 2b as maintenance therapy in poor risk diffuse large B-cell lymphoma in complete remission after intensive CHOP-BLEO regimens
    A Aviles
    Department of Hematology, Oncology Hospital, National Medical Center, IMSS, Mexico, DF, Mexico
    Eur J Haematol 66:94-9. 2001
    ....
  21. ncbi Evaluation on a six-dose treatment of anti CD 20 monoclonal antibody in patients with refractory follicular lymphoma
    A Aviles
    Senior Researcher, Oncology Diseases Research Unit, Oncology Hospital, National Medical Center, IMSS, Mexico, D F Mexico
    Cancer Biother Radiopharm 16:159-62. 2001
    ..However, the number is too short to draw definitive conclusions; more clinical trials are necessary to determine if 4 or 6 doses of anti CD 20 therapy are better in this setting of patients...
  22. ncbi Rituximab in the treatment of refractory follicular lymphoma -- six doses are better than four
    A Aviles
    Research Unit in Oncology Diseases, National Medical Center, IMSS, Mexico, D F Mexico
    J Hematother Stem Cell Res 10:313-6. 2001
    ..However, the number is too small to drawn definitive conclusions, and more clinical trials are necessary to determine if four of six doses of anti-CD20 therapy are better in this setting of patients...
  23. ncbi The role of maintenance therapy in the treatment of large-cell non-Hodgkin's lymphoma
    A Aviles
    Department of Hematology, Oncology Hospital, National Medical Center, I M S S, Mexico
    Acta Oncol 30:959-62. 1991
    ....
  24. ncbi Second lethal events associated with treatment for Hodgkin's disease: a review of 2980 patients treated in a single Mexican institute
    A Aviles
    Oncology Disease Research Unit, Oncology Hospital, National Medical Center, IMSS, Mexico, D F Mexico
    Leuk Lymphoma 39:311-9. 2000
    ....
  25. ncbi Combined therapy for angioimmunoproliferative lesions
    A Aviles
    Department of Hematology, Oncology Hospital, National Medical Center, Mexico, D F
    Eur J Cancer B Oral Oncol 30:302-4. 1994
    ..Our results show that combined therapy appears to be the best therapeutic approach in patients with this type of malignant lymphoma. More studies are necessary to define the role of combined therapy in patients with AIL...
  26. ncbi Treatment of acquired immunodeficiency syndrome-related lymphoma with a standard chemotherapy regimen
    A Aviles
    Department of Hematology, Oncology Hospital, National Medical Center, Mexico, D F, Mexico
    Ann Hematol 78:9-12. 1999
    ..The use of a standard regimen appears to be an adequate therapeutic approach in this group of patients...
  27. ncbi Angiocentric nasal T/natural killer cell lymphoma: a single centre study of prognostic factors in 108 patients
    A Aviles
    Departament of Hematology, Oncology Hospital, National Medical Center, Mexico
    Clin Lab Haematol 22:215-20. 2000
    ..There was no evidence that the international prognostic index (IPI) was applicable in these patients and it appears that angiocentric T/NK cell lymphoma is an independent prognostic factor itself...
  28. ncbi Late lethal events in patients with diffuse large B cell lymphoma: a review of 714 patients treated in a single centre
    A Aviles
    Department of Hematology, Hospital National Medical Center IMSS, Mexico, DF, Mexico
    Leuk Lymphoma 42:631-7. 2001
    ..The proposed modifications of therapy many indeed be useful to avoid or diminish these complications in the future...
  29. ncbi Long-term results in patients with low-grade nodular non-Hodgkin's lymphoma. A randomized trial comparing chemotherapy plus radiotherapy with chemotherapy alone
    A Aviles
    Department of Hematology, Oncology Hospital, Mexico City
    Acta Oncol 30:329-33. 1991
    ..Toxicity was moderate in all three arms. Bulky disease and a high level of lactic dehydrogenase were associated with a poor prognosis...
  30. ncbi High dose chemotherapy with G-CSF in refractory Hodgkin's disease
    A Aviles
    Department of Hematology, Oncology Hospital, National Medical Center México, DF Mexico
    Leuk Lymphoma 36:139-45. 1999
    ....
  31. pmc Randomized clinical trial of zoledronic acid in multiple myeloma patients undergoing high-dose chemotherapy and stem-cell transplantation
    A Aviles
    Oncology Research Unit, Oncology Hospital, National Medical Center, IMSS, Mexico DF, Mexico
    Curr Oncol 20:e13-20. 2013
    ....
  32. ncbi Long-term evaluation of cardiac function in children who received anthracyclines during pregnancy
    A Aviles
    Oncology Research Unit and Department of Hematology, Oncology Hospital National Medical Center, IMSS, Mexico, D F Mexico
    Ann Oncol 17:286-8. 2006
    ..The outcome of children that received antracyclines during pregnancy, including during the first trimester, remain unknown because long-term follow-up is not available...